Skip to content

Clinical trials

Phase 2 Central Nervous System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Phase: Phase 2 Country / region: France Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20181
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MapLight Therapeutics2
Novartis2
Alkahest, Inc.1
Bial R&D Investments, S.A.1
GlaxoSmithKline1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases8
Neurodegenerative Diseases7
Alzheimer Disease6
Brain Diseases5
Dementia5
Mental Disorders5
Nervous System Diseases5
Neurocognitive Disorders4
Tauopathies3
Hallucinations2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.